Literature DB >> 5051145

Permanent facilitation of avoidance behavior by d-amphetamine and scopolamine.

R J Barrett, N J Leith, O S Ray.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5051145     DOI： 10.1007/bf00421971

Source DB:  PubMed          Journal:  Psychopharmacologia


× No keyword cloud information.
  7 in total

Review 1.  Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part II.

Authors:  M Sarter; J Hagan; P Dudchenko
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Behavioral microanalysis of spatial delayed alternation performance: rehearsal through overt behavior, and effects of scopolamine and chlordiazepoxide.

Authors:  P Dudchenko; M Sarter
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  Latent inhibition is not affected by acute or chronic administration of 6 mg/kg dl-amphetamine.

Authors:  I Weiner; A Izraeli-Telerant; J Feldon
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  Differential effects of intra-accumbens and systemic amphetamine on latent inhibition using an on-baseline, within-subject conditioned suppression paradigm.

Authors:  A S Killcross; T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Cholinergic influences on escape deficits produced by uncontrollable stress.

Authors:  H Anisman; S J Glazier; L S Sklar
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

6.  Effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) after repeated administration on a conditioned avoidance response (CAR) in the rat.

Authors:  J L Evenden
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

7.  Amphetamine-induced disruptions of latent inhibition are reinforcer mediated: implications for animal models of schizophrenic attentional dysfunction.

Authors:  A S Killcross; A Dickinson; T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.